Enhance method development with state-of-the-art techniques and processes.
Analytical method development is the strategic selection and optimization of analytical techniques tailored to quantify a designated attribute of a drug substance or product. This multifaceted exercise employs a systematic framework for assessing and choosing methodologies that exhibit:
In addition to these criteria, the method should also be efficient and cost-effective.
We employ state-of-the-art techniques throughout our method development processes to ensure precise measurement of various critical quality attributes (CQA).
These methods encompass various types of analyses including:
For assessing defined attributes we utilize the following methods:
Identity
Isoform patterns by cIEF, CE-IEF
Quantity
Total protein content
UV absorbance
Impurity
HCP, HCD by RT-PCR
Aggregates by SE-HPLC or CE
Cell substrate impurities
Enzyme-linked immunosorbent assay (ELISA)
Reverse transcription-polymerase chain reaction (RT-PCR)
Biological Activity
Cell based assay
Binding assay (Octet® surface plasmon resonance (SPR), and ELISA assays)
Microbial testing
Microbiological tests (sterility etc.)
Endotoxin
Sterility testing
Membrane filtration
Direct Inoculation
We are a CDMO and biosimilar developer driven by the vision of positively impacting the global healthcare landscape by bringing trusted and affordable medicines to market at speed.
Committed to progression, our CDMO capabilities are designed to support you at every stage of your development and manufacturing journey. Along with our proprietary continuous bioprocess manufacturing platform, EnzeneX™, we can provide everything you need in a partner.
Through a passionately progressive approach, our cutting-edge services and method development capabilities are designed to cater to your project’s every need.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.